GBA2 and nasopharyngeal carcinoma: Marques et al. [25] reported that glucocerebrosidase 2 gene knockout and pharmacological inhibition ameliorated the manifestations of NPC, such as Purkinje cell loss, motor dysfunction, and shortened lifespan, without correcting cholesterol levels, in Npc1−/− mice.